| Nathan Aaron Lam, DPM | |
|
4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433-2522 | |
| (763) 236-6000 | |
| Not Available |
| Full Name | Nathan Aaron Lam |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 10 Years |
| Location | 4050 Coon Rapids Blvd Nw, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558775304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 1070 (Minnesota) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | TP-203 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Coon rapids, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Foot And Ankle Clinic Pa | 0840294187 | 3 |
| Allina Health System | 4587573613 | 3071 |
News Archive
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
New research indicates that young recreational and elite athletes commonly accumulate excess fluid in the bone marrow around the joint that connects the spine with the pelvis.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Accelarad's team first recognized the need for the virtualization of radiology more than 10 years ago. Over the past six years, the industry has readily adopted cloud-based medical image exchanges, as evidenced by the thousands of physicians who share nearly half a billion images via Accelarad each year.
BIOTRONIK announced today that the full cohort of 120 patients has been successfully enrolled into the physician-initiated 4EVER clinical study. Follow up is scheduled at 1, 6 and 12 months, with immediate and 6 month results potentially available in January 2012.
› Verified 7 days ago
| Provider Name | Allina Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
New research indicates that young recreational and elite athletes commonly accumulate excess fluid in the bone marrow around the joint that connects the spine with the pelvis.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Accelarad's team first recognized the need for the virtualization of radiology more than 10 years ago. Over the past six years, the industry has readily adopted cloud-based medical image exchanges, as evidenced by the thousands of physicians who share nearly half a billion images via Accelarad each year.
BIOTRONIK announced today that the full cohort of 120 patients has been successfully enrolled into the physician-initiated 4EVER clinical study. Follow up is scheduled at 1, 6 and 12 months, with immediate and 6 month results potentially available in January 2012.
› Verified 7 days ago
| Provider Name | Family Foot And Ankle Clinic Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275534885 PECOS PAC ID: 0840294187 Enrollment ID: O20060829000378 |
News Archive
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
New research indicates that young recreational and elite athletes commonly accumulate excess fluid in the bone marrow around the joint that connects the spine with the pelvis.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Accelarad's team first recognized the need for the virtualization of radiology more than 10 years ago. Over the past six years, the industry has readily adopted cloud-based medical image exchanges, as evidenced by the thousands of physicians who share nearly half a billion images via Accelarad each year.
BIOTRONIK announced today that the full cohort of 120 patients has been successfully enrolled into the physician-initiated 4EVER clinical study. Follow up is scheduled at 1, 6 and 12 months, with immediate and 6 month results potentially available in January 2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Aaron Lam, DPM 3790 117th Ln Nw, Coon Rapids, MN 55433-2666 Ph: (763) 421-7300 | Nathan Aaron Lam, DPM 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433-2522 Ph: (763) 236-6000 |
News Archive
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
New research indicates that young recreational and elite athletes commonly accumulate excess fluid in the bone marrow around the joint that connects the spine with the pelvis.
ChemoCentryx, Inc., today announced that it reported positive data with Traficet-EN™ (CCX282-B) in the Maintenance period of PROTECT-1 (Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial-1). Traficet-EN maintained a clinical remission rate (Crohn's Disease Activity Index (CDAI) less than 150) of approximately 50% in Crohn's patients over the course of 36 weeks, whereas in the placebo group remission decreased progressively from 50% to 31%.
Accelarad's team first recognized the need for the virtualization of radiology more than 10 years ago. Over the past six years, the industry has readily adopted cloud-based medical image exchanges, as evidenced by the thousands of physicians who share nearly half a billion images via Accelarad each year.
BIOTRONIK announced today that the full cohort of 120 patients has been successfully enrolled into the physician-initiated 4EVER clinical study. Follow up is scheduled at 1, 6 and 12 months, with immediate and 6 month results potentially available in January 2012.
› Verified 7 days ago
Dr. Nicole M Cullen, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Brian J Greteman, DPM, PA Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3883 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-422-0233 Fax: 763-422-9640 | |
Family Foot And Ankle Clinic, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 3790 117th Ln Nw, Coon Rapids, MN 55433 Phone: 763-421-7300 Fax: 763-421-3337 | |
Richard Peter Cervenka, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3790 117th Ln Nw, Coon Rapids, MN 55433 Phone: 763-421-7300 Fax: 763-421-3337 | |
Dr. Keith A Canter, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3790 117th Ln Nw, Coon Rapids, MN 55433 Phone: 763-571-7142 | |
Dr. David Joseph Neese, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 3790 117th Ln Nw, Coon Rapids, MN 55433 Phone: 763-421-7300 Fax: 763-421-3337 |